Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC
2021 · Nature Communications · 268 citations
https://doi.org/10.1038/s41467-021-27022-z
H
Hua Bao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
326
Papers
4.8K
Citations
37
h-index
86
i10-index
Hua Bao is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Lung Cancer Treatments and Mutations & RNA modifications and cancer. The author has an h-index of 37, co-authored 278 publications.
ORCID: 0000-0001-5774-8755Papers by this author
worksLiquid biopsies to track trastuzumab resistance in metastatic HER2-positive gastric cancer
2018 · Gut · 192 citations
https://doi.org/10.1136/gutjnl-2018-316522
Letter to the Editor: An ultra-sensitive assay using cell-free DNA fragmentomics for multi-cancer early detection
2022 · Molecular Cancer · 81 citations
https://doi.org/10.1186/s12943-022-01594-w
The developing xylem transcriptome and genome-wide analysis of alternative splicing in Populus trichocarpa(black cottonwood) populations
2013 · BMC Genomics · 68 citations
https://doi.org/10.1186/1471-2164-14-359
Gene co-expression network analysis identifies porcine genes associated with variation in Salmonella shedding
2014 · BMC Genomics · 61 citations
https://doi.org/10.1186/1471-2164-15-452
Homologous recombination deficiency in diverse cancer types and its correlation with platinum chemotherapy efficiency in ovarian cancer
2022 · BMC Cancer · 53 citations
https://doi.org/10.1186/s12885-022-09602-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat